Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research
Yarnell, E
But if any of the following apply to you, your glutathione needs are likely elevated: Chronic digestive issues (IBS, IBD, SIBO, Candida overgrowth) Chronic fatigue or poor sleep Mood symptoms: anxiety, depression, brain fog Chronic infections or a history of immune dysfunction Significant toxin or alcohol exposure Heavy training or high athletic output Metabolic issues (obesity, blood sugar dysregulation) Neurological symptoms (tinnitus, cognitive decline) Older age
L-Carnitine L-Carnitine is an amino acid that plays a critical role in energy production it transports fatty acids to the mitochondria (that powerhouse of the cell you likely heard about in science class) to be turned into a form of energy called adenosine triphosphate (ATP).21 This amino acid also shows the potential to improve exercise performance while reducing oxidative stress in response to resistance training.22 This could be why Promescent states that VitaFLUX may be able to help you recover more quickly from injury or exhaustion
Parihar and Brewer, 2010
Overexpression of FSP1 or treatment with Fer-1, a ferroptosis inhibitor, significantly reversed the apoptosis, ferroptosis, and lipid peroxidation induced by the activation of the MPO/HOCl signaling pathway, exerting neuroprotective effects
